欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/H/0607/001
药品名称Microlax 5ml Rectal Solution
活性成分
    • sodium citrate 0.45 g/dose
    • SODIUM LAURYL SULFOACETATE 0.06 g/dose
    • SORBITOL 4.46 g/dose
剂型Rectal solution
上市许可持有人JOHNSON & JOHNSON SANTE BEAUTE France 1 RUE CAMILLE DESMOULINS 92130 ISSY LES MOULINEAUX FRANCE
参考成员国 - 产品名称France (FR)
Sorbitol Citrate et Laurilsulfoacetate de Sodium Johnson & Johnson, solution rectale
互认成员国 - 产品名称
    • Italy (IT)
    • Greece (GR)
      MICROLAX
    • Poland (PL)
      Microlax
    • Hungary (HU)
      MICROLAX végbéloldat
    • Bulgaria (BG)
      Microlax 5ml Rectal Solution
    • Cyprus (CY)
      microlax rectal solution
    • Romania (RO)
    • Slovakia (SK)
      Microlax 625 mg/90 mg/9 mg/ml rektálny roztok
    • Slovenia (SI)
    • Croatia (HR)
      Microlax 4,465 g/0,45 g/0,0645 g otopina za rektum
许可日期2017/08/11
最近更新日期2024/06/26
药物ATC编码
    • A06AG11 sodium lauryl sulfoacetate, incl. combinations
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Non Prescription (including OTC)
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase